Literature DB >> 22797206

Coma in thrombotic thrombocytopenic purpura.

F J de Jong1, P A W Te Boekhorst, D W J Dippel, B C Jacobs.   

Abstract

Thrombotic thrombocytopenic purpura (TTP) is characterised by a thrombotic, haemolytic microangiopathy leading to microvascular occlusion, haemolysis and ischaemic dysfunction of various organs including the brain. TTP may present with a variety of neurological symptoms, including headache, focal deficits, seizures and coma. The authors describe a 55-year-old man presenting with abdominal pain and rapidly progressive deterioration into coma without focal neurological deficits or seizures. A concomitant, transient, rapid increase in blood pressure raised the suspicion of a hypertensive crisis. Yet, our patient did not improve after vigorous treatment with antihypertensives. Brain imaging excluded a hypertensive leucoencephalopathy. Despite the absence of a disintegrin and metalloproteinase with a thrombospondin type 1 motif member 13 (ADAMTS13) deficiency, the diagnosis idiopathic TTP was made after excluding secondary causes of TTP. Upon treatment with plasma exchange, corticosteroids and vincristin our patient gradually improved. On discharge to a rehabilitation centre he was awake and alert, had minor cognitive deficits and a mild proximal tetraparesis consistent with a critical illness poly(neuro)myopathy.

Entities:  

Mesh:

Year:  2010        PMID: 22797206      PMCID: PMC3029036          DOI: 10.1136/bcr.06.2010.3113

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Coma in thrombotic thrombocytopenic purpura.

Authors:  F E Kelly; D F Treacher; F M Williams; B J Hunt; S Howard
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-05       Impact factor: 10.154

Review 2.  Haematology and neurology.

Authors:  Steven Austin; Hannah Cohen; Nick Losseff
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04       Impact factor: 10.154

3.  Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features.

Authors:  Marie Scully; Helen Yarranton; Ri Liesner; Jamie Cavenagh; Beverley Hunt; Sylvia Benjamin; David Bevan; Ian Mackie; Samuel Machin
Journal:  Br J Haematol       Date:  2008-07-08       Impact factor: 6.998

4.  Outcome of severe adult thrombotic microangiopathies in the intensive care unit.

Authors:  Frédéric Pene; Cécile Vigneau; Marc Auburtin; Delphine Moreau; Jean-Ralph Zahar; Joël Coste; Farhad Heshmati; Jean-Paul Mira
Journal:  Intensive Care Med       Date:  2004-12-03       Impact factor: 17.440

5.  Atypical reversible posterior leukoencephalopathy syndrome in thrombotic thrombocytopenic purpura.

Authors:  Demet Funda Bas; Kader Karli Oguz; Mehmet Akif Topcuoglu
Journal:  Intern Med       Date:  2008-11-04       Impact factor: 1.271

6.  Thrombotic thrombocytopenic purpura: prolonged coma with recovery of neurologic function with intensive plasma exchange.

Authors:  A E Frankel; M D Rubenstein; R T Wall
Journal:  Am J Hematol       Date:  1981-06       Impact factor: 10.047

Review 7.  Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.

Authors:  J Evan Sadler
Journal:  Blood       Date:  2008-07-01       Impact factor: 22.113

8.  Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension.

Authors:  Bert-Jan H van den Born; Niels V van der Hoeven; Evelyn Groot; Peter J Lenting; Joost C M Meijers; Marcel Levi; Gert A van Montfrans
Journal:  Hypertension       Date:  2008-03-10       Impact factor: 10.190

  8 in total
  1 in total

Review 1.  The standard of care for immune thrombotic thrombocytopenic purpura today.

Authors:  X Long Zheng
Journal:  J Thromb Haemost       Date:  2021-06-30       Impact factor: 16.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.